$19.2 Billion is the total value of VIKING GLOBAL INVESTORS LP's 62 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LIFE | Exit | ATYR PHARMA INC | $0 | – | -3,209,955 | -100.0% | -0.01% | – |
| EIDX | Exit | EIDOS THERAPEUTICS INC | $0 | – | -882,353 | -100.0% | -0.12% | – |
| AIG | Exit | AMERICAN INTL GROUP INC | $0 | – | -564,604 | -100.0% | -0.14% | – |
| CHWY | Exit | CHEWY INCcl a | $0 | – | -1,471,890 | -100.0% | -0.23% | – |
| NXPI | Exit | NXP SEMICONDUCTORS N V | $0 | – | -670,065 | -100.0% | -0.29% | – |
| BERY | Exit | BERRY GLOBAL GROUP INC | $0 | – | -1,804,817 | -100.0% | -0.43% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -371,450 | -100.0% | -0.48% | – |
| AOS | Exit | SMITH A O CORP | $0 | – | -2,452,092 | -100.0% | -0.52% | – |
| NVDA | Exit | NVIDIA CORP | $0 | – | -802,330 | -100.0% | -0.59% | – |
| DVA | Exit | DAVITA INC | $0 | – | -2,907,034 | -100.0% | -0.73% | – |
| WORK | Exit | SLACK TECHNOLOGIES INC | $0 | – | -4,539,615 | -100.0% | -0.76% | – |
| MU | Exit | MICRON TECHNOLOGY INC | $0 | – | -6,431,167 | -100.0% | -1.11% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -4,812,185 | -100.0% | -5.27% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VISA INC | 36 | Q3 2023 | 7.0% |
| AMAZON COM INC | 34 | Q3 2023 | 10.6% |
| META PLATFORMS INC | 34 | Q3 2023 | 10.4% |
| MICROSOFT CORP | 30 | Q3 2023 | 9.1% |
| THERMO FISHER SCIENTIFIC INC | 29 | Q3 2023 | 5.4% |
| NETFLIX INC | 26 | Q2 2023 | 6.0% |
| MASTERCARD INCORPORATED | 25 | Q3 2023 | 3.9% |
| ELEVANCE HEALTH INC | 24 | Q2 2023 | 10.2% |
| ALPHABET INC | 22 | Q2 2021 | 9.3% |
| UNITEDHEALTH GROUP INC | 22 | Q3 2023 | 5.3% |
View VIKING GLOBAL INVESTORS LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Celldex Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Coupa Software IncSold out | February 14, 2023 | 0 | 0.0% |
| FIGS, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Guardant Health, Inc. | February 14, 2023 | 4,107,644 | 4.0% |
| Orion Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| PROCEPT BioRobotics CorpSold out | February 14, 2023 | 0 | 0.0% |
| Frazier Lifesciences Acquisition CorpSold out | November 25, 2022 | 0 | 0.0% |
| Cazoo Group Ltd | November 10, 2022 | 60,000,000 | 7.3% |
| AbCellera Biologics Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View VIKING GLOBAL INVESTORS LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 3 | 2024-03-20 |
| SC 13G/A | 2024-03-20 |
| 4 | 2024-03-07 |
| 4 | 2024-03-07 |
| 4 | 2024-03-01 |
| 4 | 2024-03-01 |
| SC 13G/A | 2024-03-01 |
| 4 | 2024-02-28 |
| 4 | 2024-02-28 |
View VIKING GLOBAL INVESTORS LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.